Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer

NCT02418312 is registered in ClinicalTrials.gov with Kaohsiung Veterans General Hospital. as lead sponsor.

NCT NCT02418312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02418312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer
Lead sponsor
Kaohsiung Veterans General Hospital.
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2012
Completion date
October 31, 2017
Enrollment
228 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peptic ulcer